Toyomasa Katagiri
Directeur/Membre du Conseil chez Cancer Precision Medicine KK
Provenance du réseau au premier degré de Toyomasa Katagiri
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 9 | |
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Cancer Precision Medicine KK
1
| Private Company | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Toyomasa Katagiri via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Dojin Iyaku-Kako Co., Ltd.
 Dojin Iyaku-Kako Co., Ltd. Pharmaceuticals: MajorHealth Technology Dojin Iyaku-Kaku Co., Ltd. is engaged in the development, production, and distribution of pharmaceutical products and pharmaceutical raw materials. The company was established in 1946 and is based in Tokyo, Japan. | Pharmaceuticals: Major | President | |
| University of Tokyo | College/University | Doctorate Degree | |
| Seoul National University | College/University | Graduate Degree | |
| Iwate Medical University | College/University | Undergraduate Degree | |
| Sun Life Members Co., Ltd. | Comptroller/Controller/Auditor | ||
| Laboratoires OncoTherapy Science France SARL | Director/Board Member Corporate Officer/Principal | ||
G&G Science Co., Ltd.
 G&G Science Co., Ltd. Miscellaneous Commercial ServicesCommercial Services G&G Science Co., Ltd. provides research and development services for DNA analysis and consulting. The private company is based in Fukushima, Japan. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
HanaVax, Inc.
 HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Biotechnology | Comptroller/Controller/Auditor | |
| SUN-LIFE HOLDING CO.,LTD. | Other Consumer Services | Director/Board Member | |
| Seoul National University College of Veterinary Medicine | College/University | Undergraduate Degree |
Statistiques
Internationale
| Japon | 8 |
| Corée du Sud | 3 |
| France | 2 |
Sectorielle
| Consumer Services | 6 |
| Health Technology | 3 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 17 |
| President | 8 |
| Comptroller/Controller/Auditor | 6 |
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 5 |
Relations les plus connectées
- Bourse
- Insiders
- Toyomasa Katagiri
- Connexions Sociétés
